BioSpace News Archive

Buntanetap, previously known as ANVS401 or Posiphen, is sometimes mistaken for phenserine.

Tarsier Pharma, an advanced clinical stage pharmaceutical company focused on the development and commercialization of novel therapeutics for blinding ocular diseases, announced that it has launched an education website about the disease uveitic glaucoma at www.uveiticglaucoma.com, as a service to the public.

Enteris BioPharma, Inc. provided a review of its 2021 business achievements and development activities as the company anticipates growth opportunities during 2022 involving its industry-leading Peptelligence® and ProPerma® oral peptide and small molecule delivery technologies, and extensive pharmaceutical expertise.

Catalent today announced that its Board of Directors has appointed Alessandro Maselli, currently President and Chief Operating Officer, as the company’s next President and Chief Executive Officer, effective July 1, 2022.